sk&f-38393 has been researched along with phencyclidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggan, WO; Faught, K; Middaugh, LD | 1 |
| Breese, GR; Moy, SS | 1 |
| Fletcher, PJ; Kapur, S; Lovic, V; Rizos, Z; Tenn, CC | 1 |
| Idris, NF; McLean, SL; Neill, JC; Woolley, ML | 1 |
| Adelekun, AE; Hannaway, KE; Horiguchi, M; Huang, M; Jayathilake, K; Meltzer, HY | 1 |
| Barnes, SA; Bate, ST; Neill, JC; Young, JW | 1 |
6 other study(ies) available for sk&f-38393 and phencyclidine
| Article | Year |
|---|---|
Effect of dopaminergic drugs on enhancement of the binding of quinuclidinyl benzilate by phencyclidine in vivo.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atropine; Benzazepines; Dopamine; Dopamine Agents; Ergolines; Hydroxydopamines; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidopamine; Phencyclidine; Quinpirole; Quinuclidines; Quinuclidinyl Benzilate | 1989 |
Phencyclidine supersensitivity in rats with neonatal dopamine loss.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Benzodiazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Ketamine; Male; Motor Activity; Olanzapine; Oxidopamine; Phencyclidine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Sex Factors | 2002 |
Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Dopamine Uptake Inhibitors; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Motor Activity; Phencyclidine; Prefrontal Cortex; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2005 |
D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Behavior, Animal; Benzazepines; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Neuropsychological Tests; Phencyclidine; Receptors, Dopamine D1; Recognition, Psychology | 2009 |
D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Female; Isoindoles; Phencyclidine; Piperazines; Pyrimidines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Recognition, Psychology; Serotonin 5-HT1 Receptor Agonists | 2013 |
Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Attention; Disease Models, Animal; Dopamine Agonists; Female; Inhibition, Psychological; Neuropsychological Tests; Phencyclidine; Psychomotor Performance; Psychotropic Drugs; Rats; Receptors, Dopamine D1; Schizophrenic Psychology; Treatment Outcome | 2016 |